Secondary care treatment of patients with varicose veins in National Health Service England: at least how it appeared on a National Health Service website

Phlebology
C S LimA H Davies

Abstract

This study aimed to assess the trends and regional variations in secondary care treatment of patients with varicose veins in National Health Service (NHS) England based on data published by the Hospital Episode Statistics which was freely and readily available to the public and health-care policy-makers. Hospital Episode Statistics data for patients being treated for varicose veins, and UK Statistics Authority population estimates in all 28 Strategic Health Authorities (SHAs) in England from 2002 to 2006 were retrieved and analysed. Between 2002 and 2006 there was a 20% overall reduction (46,190-37,135) in the total number of varicose vein procedures performed in NHS England per year. The number of varicose vein procedures performed per 100,000 population per year varied significantly across the SHAs (P < 0.0001). Similarly, significant regional variations were also noted in the frequency of primary procedures of greater and small saphenous vein (P < 0.0001). During this time, injection sclerotherapy was only performed in 15 (53.6%) SHAs. The annual proportion of varicose vein procedures performed as daycases had increased from 56% to 64% during the period. From 2002 to 2006 there was an overall reduction in the total number of...Continue Reading

References

Feb 1, 1994·The British Journal of Surgery·M J Callam
Mar 31, 2000·BMJ : British Medical Journal·B WilliamsL Rushton
Mar 26, 2003·Journal of Clinical Epidemiology·Amanda J LeeF Gerald R Fowkes
Feb 8, 2006·Annals of the Royal College of Surgeons of England·Mark R E HarrisJohn F Chester
Sep 29, 2006·Health Economics·Julie RatcliffeJonathan Michaels
Sep 4, 2008·Annals of the Royal College of Surgeons of England·M K NasrM Horrocks
Nov 8, 2008·Annals of the Royal College of Surgeons of England·A G EdwardsD C Mitchell
Feb 2, 2010·Phlebology·A C ShepherdA H Davies

❮ Previous
Next ❯

Citations

May 18, 2010·The British Journal of Surgery·A C ShepherdA H Davies
Nov 12, 2015·Phlebology·Sarah OnidaIan Franklin
Sep 20, 2012·Phlebology·T R A LaneA H Davies
Feb 15, 2012·Phlebology·M A AnwarI J Franklin
Nov 22, 2018·Journal of Clinical Nursing·Elizabeth LumleyJonathan A Michaels
Jul 26, 2011·Acta chirurgica Belgica·T R A LaneA H Davies
Apr 11, 2019·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C MolnarC Nicolescu
Apr 10, 2020·Phlebology·Francine HeatleyAlun H Davies

❮ Previous
Next ❯

Software Mentioned

StatsDirect

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.